IRADIMED CORPORATION Announces First Quarter 2022 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/1/2026
- Wall Street ends lower as higher yields, rising oil prices mark shaky start to September
- Oil prices jump 4% as fresh US-Iran fighting stokes supply fears
- Two Saudi tankers struck in Strait of Hormuz Monday
- Dell again lifts annual forecasts as AI demand powers record results
- Fed’s Barr backs rate hike if inflation fails to cool, September odds hit 66%
IRadimed Corp (IRMD) Mentioned Positively at Roth Capital, 'Solid Fundamentals'
May 2, 2022 10:58 AM EDTRoth Capital analyst Scott R. Henry lowered the price target on IRadimed Corp (NASDAQ: IRMD) to $40.00 (from $53.00) while maintaining a Buy rating.
The analyst comments "IRMD reported 1Q22 results that were modestly ahead of our expectations. The key takeaways, in our opinion,... More
